TipRanks
Anika Therapeutics (DE:AKP)
FRANKFURT:AKP
Germany Market
AKP
Anika Therapeutics
RESEARCH TOOLSreports

Anika Therapeutics (AKP) Ratios

0 Followers

Anika Therapeutics Ratios

DE:AKP's free cash flow for Q2 2026 was $0.65. For the 2026 fiscal year, DE:AKP's free cash flow was decreased by $ and operating cash flow was $0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.48 4.72 4.88 5.26 6.07
Quick Ratio
 3.19 3.86 3.85 4.47 4.65
Cash Ratio
 1.73 2.62 2.39 2.21 3.09
Solvency Ratio
 0.04 -0.11 -0.99 -1.17 >-0.01
Operating Cash Flow Ratio
 0.27 0.51 0.23 -0.06 0.16
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 53.00M$ 56.55M$ 64.90M$ 104.94M$ 105.98M
Leverage Ratios
Debt-to-Assets Ratio
 0.13 0.14 0.13 0.10 0.09
Debt-to-Equity Ratio
 0.17 0.18 0.17 0.13 0.11
Debt-to-Capital Ratio
 0.15 0.15 0.14 0.12 0.10
Long-Term Debt-to-Capital Ratio
 0.15 0.14 0.00 0.00 0.00
Financial Leverage Ratio
 1.34 1.33 1.32 1.27 1.22
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.08 0.18 0.00 0.00 0.00
Interest Debt Per Share
 1.74 1.83 1.76 1.89 2.12
Net Debt to EBITDA
 -5.56 8.73 -5.54 -2.72 -3.05
Profitability Margins
Gross Profit Margin
62.16%56.56%63.38%68.33%64.33%
EBIT Margin
-2.41%-8.25%-2.31%0.70%3.22%
EBITDA Margin
2.25%-3.17%4.47%12.47%15.95%
Operating Profit Margin
-4.24%-9.80%-4.25%0.70%3.22%
Pretax Profit Margin
-2.41%-8.25%-2.31%2.61%3.80%
Net Profit Margin
-3.14%-9.64%-47.02%-68.44%-13.05%
Continuous Operations Profit Margin
-2.59%-8.85%-7.36%-2.85%1.93%
Net Income Per EBT
129.90%116.90%2039.98%-2619.36%-343.64%
EBT Per EBIT
56.88%84.22%54.19%373.93%117.82%
Return on Assets (ROA)
-2.06%-5.72%-27.81%-30.55%-4.26%
Return on Equity (ROE)
-2.70%-7.58%-36.62%-38.95%-5.20%
Return on Capital Employed (ROCE)
-3.17%-6.56%-2.84%0.35%1.14%
Return on Invested Capital (ROIC)
-3.17%-6.48%-2.81%-0.38%0.58%
Return on Tangible Assets
-2.17%-6.03%-29.20%-31.74%-5.56%
Earnings Yield
-1.34%-7.90%-23.27%-24.89%-3.45%
Efficiency Ratios
Receivables Turnover
 4.15 4.76 5.08 4.58 3.29
Payables Turnover
 7.32 8.11 7.82 6.18 4.48
Inventory Turnover
 1.60 2.61 1.84 1.57 1.02
Fixed Asset Turnover
 1.85 1.70 1.85 1.86 1.44
Asset Turnover
 0.66 0.59 0.59 0.45 0.33
Working Capital Turnover Ratio
 1.61 1.31 1.08 0.88 0.81
Cash Conversion Cycle
 266.45 171.57 223.04 253.60 386.90
Days of Sales Outstanding
 87.92 76.64 71.82 79.65 111.04
Days of Inventory Outstanding
 228.39 139.91 197.92 233.04 357.43
Days of Payables Outstanding
 49.86 44.99 46.69 59.09 81.56
Operating Cycle
 316.31 216.55 269.74 312.70 468.47
Cash Flow Ratios
Operating Cash Flow Per Share
 0.45 0.78 0.37 -0.12 0.30
Free Cash Flow Per Share
 0.04 0.30 -0.16 -0.49 -0.21
CapEx Per Share
 0.40 0.48 0.53 0.37 0.51
Free Cash Flow to Operating Cash Flow
 0.09 0.39 -0.43 4.04 -0.70
Dividend Paid and CapEx Coverage Ratio
 1.10 1.64 0.70 -0.33 0.59
Capital Expenditure Coverage Ratio
 1.10 1.64 0.70 -0.33 0.59
Operating Cash Flow Coverage Ratio
 0.26 0.43 0.21 -0.06 0.14
Operating Cash Flow to Sales Ratio
 0.05 0.10 0.05 -0.01 0.04
Free Cash Flow Yield
0.20%3.17%-0.96%-2.17%-0.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -77.33 -12.64 -4.30 -4.02 -29.01
Price-to-Sales (P/S) Ratio
 2.31 1.22 2.02 2.75 3.79
Price-to-Book (P/B) Ratio
 2.04 0.96 1.57 1.56 1.51
Price-to-Free Cash Flow (P/FCF) Ratio
 496.27 31.59 -103.95 -46.03 -140.07
Price-to-Operating Cash Flow Ratio
 46.83 12.32 44.85 -185.74 97.76
Price-to-Earnings Growth (PEG) Ratio
 -0.27 0.16 0.13 >-0.01 0.06
Price-to-Fair Value
 2.04 0.96 1.57 1.56 1.51
Enterprise Value Multiple
 97.09 -29.78 39.69 19.33 20.68
Enterprise Value
 266.35M 106.56M 212.61M 291.11M 375.57M
EV to EBITDA
 98.03 -29.78 39.69 19.33 20.68
EV to Sales
 2.21 0.94 1.77 2.41 3.30
EV to Free Cash Flow
 473.93 24.43 -91.21 -40.35 -122.06
EV to Operating Cash Flow
 44.56 9.52 39.35 -162.81 85.18
Tangible Book Value Per Share
 9.52 9.33 9.81 13.79 13.98
Shareholders’ Equity Per Share
 10.22 10.01 10.46 14.48 19.61
Tax and Other Ratios
Effective Tax Rate
 -0.07 -0.07 -2.19 2.09 0.49
Revenue Per Share
 8.98 7.87 8.15 8.24 7.82
Net Income Per Share
 -0.28 -0.76 -3.83 -5.64 -1.02
Tax Burden
 1.30 1.17 20.40 -26.19 -3.44
Interest Burden
 1.00 1.00 1.00 3.74 1.18
Research & Development to Revenue
 0.23 0.23 0.21 0.18 0.16
SG&A to Revenue
 0.44 0.44 0.46 0.00 0.00
Stock-Based Compensation to Revenue
 0.11 0.09 0.11 0.13 0.13
Income Quality
 -1.58 -1.03 -0.10 0.02 -0.30
Currency in USD